The Contribution of Spirulina Platensis Supplementation on COVID-19 Prevention and Hospitalization



Abstract Views
3761

Downloads
641

Citations

Share

##plugins.themes.bootstrap3.article.sidebar##

Submitted May 4, 2022
Published May 30, 2022
10.24018/ejmed.2022.4.3.1355

Abstract viewed = 3761 times

Table of Contents

##plugins.themes.bootstrap3.article.main##

Background & Aims: Spirulina is a filamentous cyanobacterium known for its high nutritional value and therapeutic properties. The aim of this study was to investigate the role of Spirulina supplementation on coronavirus disease 2019 (COVID-19) prevention and hospitalization.

Methods: We studied the state of health among 186 (median age: 47, range: 30-60 years) Greek individuals, non-vaccinated against the COVID-19, for 6 months. Among these, 102 unvaccinated individuals received orally 6 g Spirulina (Arthrospira platensis) daily for 6 months. Anthropometric characteristics (height, weight, body mass index / BMI), systolic and diastolic blood pressure, complete blood count and biochemical assessments, were recorded and measured before Spirulina supplementation.

Results: Among the 102 unvaccinated individuals who received Spirulina, only 14 (13.7%) contracted SARS-CoV2 (confirmed Delta variant) with mild symptoms and 2 (1.9%) needed hospitalization because of acute viral gastroenteritis. In contrast, among the 84 unvaccinated individuals who did not receive Spirulina, 62 (73.8%) contracted SARS-CoV2 (confirmed Delta variant) with mild symptoms and 17 (20.2%) needed hospitalization. None of the hospitalized patients died.

Conclusions: Spirulina supplementation at a dose of 6 g daily can contribute to the war against SARS-CoV2, preventing COVID-19 and reducing the need for hospitalization.

Keywords: COVID-19, hospitalization, prevention, Spirulina

Downloads

Download data is not yet available.

References

  1. Mazokopakis EE, Starakis IK, Papadomanolaki MG, Mavroeidi NG, Ganotakis ES. The hypolipidaemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population: a prospective study. J Sci Food Agric. 2014; 94(3): 432-437.
    DOI  |   Google Scholar
  2. Ratha SK, Renuka N, Rawat I, Bux F. Prospective options of algae-derived nutraceuticals as supplements to combat COVID-19 and human coronavirus diseases. Nutrition. 2021; 83: 111089.
    DOI  |   Google Scholar
  3. Chia WY, Kok H, Chew KW, Low SS, Show PL. Can algae contribute to the war with Covid-19? Bioengineered. 2021; 12(1): 1226-1237.
    DOI  |   Google Scholar